<menu id="icyyc"></menu>
  • <nav id="icyyc"></nav>
    <menu id="icyyc"><strong id="icyyc"></strong></menu>
    <menu id="icyyc"></menu>
  • 這是描述信息

    New Center
    Check category
    /
    /
    Industry News
    04-26

    36 supplementary application fees for drug registration, and the prices are clearly marked item by item!

    As the country has issued new drug registration fees, the editor can understand the new drug registration fees and generic drug registration fees. For the supplementary application fees, it is a bit dizzy. First, there are as many as 36 supplementary application items. Second, the same supplementary application items may also have regular items and items requiring technical review, and the charging standards are quite different.   Drug registration fee    Note: 1. The drug registration fee is charged based on a raw material drug or a preparation as a variety. If another specification is added, the registration fee will be increased by 20% according to the corresponding category.    2. In the , it belongs to the provincial food and drug supervision and management
    04-26

    Tao Jianhong talks about how to do a good job of market analysis in new drug research and development projects

    The "beautiful philosophy" of Chinese innovation    "No one can assert that pharmaceutical innovation in the midst of opportunities, cooperation, transformation, and complex global competition will eventually go. But we know that history will not turn back; and no one can It is predicted that under the combined effect of wealth, policy, technology, and culture, how much potential pharmaceutical companies have that can be stimulated. We only know that the future is always beyond imagination!" Deputy Director, Southern Institute of Pharmaceutical Economics, "Pharmaceutical Economics" Tao Jianhong, editor-in-chief of the newspaper, said in an exclusive interview: “The premise of innovative thinking in the research and development of new drugs is a kind of conjecture about market demand.
    04-26

    Quality Consistency Evaluation Work Plan of Generic Drugs

    Generic drugs are alternative drugs that have the same active ingredients, dosage forms, routes of administration, and therapeutic effects as the generic drugs. They have important economic and social benefits such as reducing medical expenditures, increasing the availability of drugs, and improving the level of medical services. Due to the relatively weak medical research foundation of the early approved generic drugs, the quality of some generic drugs is far from that of the generic drugs, and the clinical efficacy of the generic drugs cannot be achieved. Improving the quality of the generic drugs is of great significance to the maintenance of public health. The "Twelfth Five-Year Plan for National Drug Safety" clearly states that it will take 5-10 years to copy the "Administrative Measures for Drug Registration" revised in 2007 before implementation
    Previous page
    1

    Copyright ? Shanghai Shenmei Pharmaceutical Development Technology Co., Ltd.  All Rights Reserved     滬ICP備17050915號-4     POWERED BY 300.CN

    久久精品人人做人人爽电影-男女十八禁啪啪无遮挡床震-40岁大乳的熟妇在线观看 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>